About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 680642, 12 pages
http://dx.doi.org/10.1155/2011/680642
Review Article

Animal Models of Bacterial Keratitis

Department of Microbiology, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA

Received 16 October 2010; Revised 29 November 2010; Accepted 9 December 2010

Academic Editor: Oreste Gualillo

Copyright © 2011 Mary E. Marquart. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Thygeson, “The treatment of trachoma with sulfanilamide: a report of 28 cases,” American Journal of Ophthalmology, vol. 37, pp. 395–403, 1939.
  2. M. J. Freyche, “Antibiotics and sulfonamides in the treatment of trachoma,” Bulletin of the World Health Organization, vol. 2, no. 4, pp. 523–544, 1950. View at Scopus
  3. L. de Andrade, “Trachoma; diagnosis and treatment,” The British Journal of Ophthalmology, vol. 35, no. 10, pp. 601–606, 1951. View at Scopus
  4. S. K. Allen and R. D. Semba, “The trachoma “menace” in the United States, 1897–1960,” Survey of Ophthalmology, vol. 47, no. 5, pp. 500–509, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Sorsby and I. Kane, “Optimal methods in the treatment of ophthalmia neonatorum,” British Medical Journal, vol. 2, no. 4627, pp. 562–565, 1949.
  6. H. L. Ormsby, “Ophthalmia neonatorum,” Canadian Medical Association Journal, vol. 72, no. 8, pp. 576–580, 1955. View at Scopus
  7. C. A. Smith and L. Halse, “Ophthalmia neonatorum,” Public Health Reports, vol. 70, no. 5, pp. 462–470, 1955. View at Scopus
  8. D. P. Choyce and A. G. Cross, “An eye sanatorium; survey of one years' work,” The British Journal of Ophthalmology, vol. 37, no. 7, pp. 405–414, 1953. View at Scopus
  9. L. P. Agarwal and B. M. Gupta, “Sulphonamides and antibiotic drugs in the treatment of trachoma,” The British Journal of Ophthalmology, vol. 38, no. 2, pp. 119–122, 1954. View at Scopus
  10. R. R. Button, “Treatment of trachoma with erythromycin. A preliminary report of 21 cases,” American Journal of Ophthalmology, vol. 39, no. 2, pp. 223–227, 1955. View at Scopus
  11. Y. Mitsui, K. Yamashita, and J. Hanabusa, “Treatment of trachoma with tetracycline,” Antibiotic Medicine and Clinical Therapy, vol. 1, no. 4, pp. 225–226, 1955. View at Scopus
  12. H. Rais, “First attempts at treatment of trachoma with erythromycin.Premiers essais de traitement du trachome par l'éythromycine,” Revue Internationale du Trachome, vol. 32, no. 4, pp. 459–462, 1955. View at Scopus
  13. P. J. Kozinn, A. Minsky, and E. Solomons, “Oxytetracycline ophthalmic solution in the prophylaxis of ophthalmia neonatorum,” Antibiotics Annual, vol. 3, pp. 307–312, 1955. View at Scopus
  14. Y. Mitsui and K. Yamashita, “Tetracycline and tetracycline-hydrocortisone oil suspensions in trachoma,” Antibiotics Annual, vol. 3, pp. 324–330, 1955. View at Scopus
  15. M. L. Durand and C. H. Dohlman, “Successful prevention of bacterial endophthalmitis in eyes with the boston keratoprosthesis,” Cornea, vol. 28, no. 8, pp. 896–901, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. J. Suzuki, K. Oh-I, T. Kezuka, J. I. Sakai, and H. Goto, “Comparison of patients with ocular tuberculosis in the 1990s and the 2000s,” Japanese Journal of Ophthalmology, vol. 54, no. 1, pp. 19–23, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. C. C. Wykoff, M. B. Parrott, H. W. Flynn Jr., W. Shi, D. Miller, and E. C. Alfonso, “Nosocomial acute-onset postoperative endophthalmitis at a university teaching hospital (2002–2009),” American Journal of Ophthalmology, vol. 150, no. 3, pp. 392–398.e2, 2010. View at Publisher · View at Google Scholar · View at PubMed
  18. J. M. Moreau, L. L. Conerly, E. B. H. Hume et al., “Effectiveness of mupirocin and polymyxin B in experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens keratitis,” Cornea, vol. 21, no. 8, pp. 807–811, 2002. View at Publisher · View at Google Scholar
  19. P. C. Hessburg, J. P. Truant, and W. P. Penn, “Pseudomonas infections of the cornea in rabbits: an in vivo comparison of polymixin B and colistin sulfate,” in Proceedings of the 2nd Interscience Conference on Antimicrobial Agents and Chemotherapy, J. C. Sylvester, Ed., pp. 131–139, American Society for Microbiology, Chicago, Ill, USA, October-November 1962.
  20. L. A. Wilson, “Chelation in experimental Pseudomonas keratitis,” British Journal of Ophthalmology, vol. 54, no. 9, pp. 587–593, 1970.
  21. W. P. Penn, J. P. Truant, and P. C. Hessburg, “Evaluation of colistin sulfate and the sulfonamides in the in vitro and in vivo treatment of Pseudomonas corneal ulcers,” Antimicrobial Agents and Chemotherapy, vol. 161, pp. 411–419, 1963.
  22. E. Kessler, B. J. Mondino, and S. I. Brown, “The corneal response to Pseudomonas aeruginosa: histopathological and enzymatic characterization,” Investigative Ophthalmology & Visual Science, vol. 16, no. 2, pp. 116–125, 1977.
  23. J. A. Hobden, L. S. Engel, M. C. Callegan, J. M. Hill, B. M. Gebhardt, and R. J. O'Callaghan, “Pseudomonas aeruginosa keratitis in leukopenic rabbits,” Current Eye Research, vol. 12, no. 5, pp. 461–467, 1993.
  24. B. H. Iglewski, R. P. Burns, and I. K. Gipson, “Pathogenesis of corneal damage from Pseudomonas exotoxin A,” Investigative Ophthalmology & Visual Science, vol. 16, no. 1, pp. 73–76, 1977.
  25. B. A. Thibodeaux, A. R. Caballero, M. E. Marquart, J. Tommassen, and R. J. O'Callaghan, “Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida,” Current Eye Research, vol. 32, no. 4, pp. 373–386, 2007. View at Publisher · View at Google Scholar · View at PubMed
  26. M. R. Sawusch, T. P. O'Brien, J. D. Dick, and J. D. Gottsch, “Use of collagen corneal shields in the treatment of bacterial keratitis,” American Journal of Ophthalmology, vol. 106, no. 3, pp. 279–281, 1988.
  27. H. Moreira, P. J. McDonnell, A. P. Fasano, D. L. Silverman, T. D. Coates, and A. Sevanian, “Treatment of experimental Pseudomonas keratitis with cyclo-oxygenase and lipoxygenase inhibitors,” Ophthalmology, vol. 98, no. 11, pp. 1693–1697, 1991.
  28. T. E. Clinch, J. A. Hobden, J. M. Hill, R. J. O'Callaghan, L. S. Engel, and H. E. Kaufman, “Collagen shields containing tobramycin for sustained therapy (24 hours) of experimental Pseudomonas keratitis,” CLAO Journal, vol. 18, no. 4, pp. 245–247, 1992.
  29. D. S. Rootman and M. Krajden, “Continuous flow perfusion of gentamicin with a scleral shell reduces bacterial colony counts in experimental Pseudomonas keratitis,” Journal of Ocular Pharmacology, vol. 9, no. 3, pp. 271–276, 1993.
  30. L. S. Engel, M. C. Callegan, J. M. Hill, A. T. Folkens, Y. Shimomura, and R. J. O'Callaghan, “The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis,” Japanese Journal of Ophthalmology, vol. 40, no. 2, pp. 212–219, 1996.
  31. S. Nos-Barbera, M. Portoles, A. Morilla, J. Ubach, D. Andreu, and C. A. Paterson, “Effect of hybrid peptides of cecropin a and melittin in an experimental model of bacterial keratitis,” Cornea, vol. 16, no. 1, pp. 101–106, 1997.
  32. R. P. Kowalski, E. G. Romanowski, K. A. Yates, and Y. J. Gordon, “Lomefloxacin is an effective treatment of experimental bacterial keratitis,” Cornea, vol. 20, no. 3, pp. 306–308, 2001. View at Publisher · View at Google Scholar
  33. I. S. Barequet, P. Denton, G. J. Osterhout, S. Tuli, and T. P. O'Brien, “Treatment of experimental bacterial keratitis with topical trovafloxacin,” Archives of Ophthalmology, vol. 122, no. 1, pp. 65–69, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. E. Aliprandis, J. Ciralsky, H. Lai, I. Herling, and H. R. Katz, “Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits,” Cornea, vol. 24, no. 2, pp. 201–205, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Frucht-Pery, F. Raiskup, H. Mechoulam, M. Shapiro, E. Eljarrat-Binstock, and A. Domb, “Iontophoretic treatment of experimental Pseudomonas keratitis in rabbit eyes using gentamicin-loaded hydrogels,” Cornea, vol. 25, no. 10, pp. 1182–1186, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. P. Bu, P. S. Riske, N. E. Zaya, R. Carey, and C. S. Bouchard, “A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis,” Journal of Ocular Pharmacology and Therapeutics, vol. 23, no. 3, pp. 213–220, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. F. S. Mah, E. G. Romanowski, R. P. Kowalski, K. A. Yates, and Y. J. Gordon, “Zymar (gatifloxacin 0.3%) shows excellent gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand white rabbit keratitis model,” Cornea, vol. 26, no. 5, pp. 585–588, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. Y. Onlen, C. Tamer, H. Oksuz, N. Duran, M. E. Altug, and S. Yakan, “Comparative trial of different anti-bacterial combinations with propolis and ciprofloxacin on Pseudomonas keratitis in rabbits,” Microbiological Research, vol. 162, no. 1, pp. 62–68, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. C. McCormick, A. Caballero, A. Tang, C. Balzli, J. Song, and R. O'Callaghan, “Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis,” Current Medical Research and Opinion, vol. 24, no. 6, pp. 1569–1575, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. D. Sensoy, E. Cevher, A. Sarici, M. Yilmaz, A. Özdamar, and N. Bergişadi, “Bioadhesive sulfacetamide sodium microspheres: evaluation of their effectiveness in the treatment of bacterial keratitis caused by Staphylococcus aureus and Pseudomonas aeruginosa in a rabbit model,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 72, no. 3, pp. 487–495, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. R. P. Kowalski, E. G. Romanowski, F. S. Mah, R. M. Q. Shanks, and Y. J. Gordon, “Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models,” Acta Ophthalmologica, vol. 88, no. 4, pp. e120–e125, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. E. Stangogiannis-Druya, C. Stangogiannis-Druya, R. Naranjo-Tackman, V. Vanzzini, and J. Villar-Kurí, “Bacterial corneal ulcer treated with intrastromal antibiotic. Experimental model in vivo,” Archivos de la Sociedad Espanola de Oftalmologia, vol. 84, no. 3, pp. 123–132, 2009. View at Scopus
  43. W. K. Blaylock, B. Y. J. T. Yue, and J. B. Robin, “The use of concanavalin A to competitively inhibit Pseudomonas aeruginosa adherence to rabbit corneal epithelium,” CLAO Journal, vol. 16, no. 3, pp. 223–227, 1990. View at Scopus
  44. J. Frucht-Pery, G. Golan, I. Hemo, H. Zauberman, and M. Shapiro, “Efficacy of topical gentamicin treatment after 193-nm photorefractive keratectomy in an experimental Pseudomonas keratitis model,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 233, no. 8, pp. 532–534, 1995.
  45. M. J. Mannis, “The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis,” Transactions of the American Ophthalmological Society, vol. 100, pp. 243–271, 2002. View at Scopus
  46. K. Michalová, A. L. Moyes, S. Cameron et al., “Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis,” Cornea, vol. 15, no. 5, pp. 533–536, 1996. View at Scopus
  47. J. M. Koch, M. F. Refojo, L. A. Hanninen, F. L. Leong, and K. R. Kenyon, “Experimental Pseudomonas aeruginosa keratitis from extended wear of soft contact lenses,” Archives of Ophthalmology, vol. 108, no. 10, pp. 1453–1459, 1990. View at Scopus
  48. E. B. Brockman, P. A. Tarantino, J. A. Hobden et al., “Keratotomy model of Pseudomonas keratitis: gentamicin chemotherapy,” Refractive and Corneal Surgery, vol. 8, no. 1, pp. 39–43, 1992. View at Scopus
  49. C. A. Lawin-Brussel, M. F. Refojo, F. L. Leong, L. Hanninen, and K. R. Kenyon, “Effect of Pseudomonas aeruginosa concentration in experimental contact lens-related microbial keratitis,” Cornea, vol. 12, no. 1, pp. 10–18, 1993. View at Publisher · View at Google Scholar · View at Scopus
  50. O. D. Solomon, H. Loff, B. Perla et al., “Testing hypotheses for risk factors for contact lens-associated infectious keratitis in an animal model,” CLAO Journal, vol. 20, no. 2, pp. 109–113, 1994. View at Scopus
  51. M. I. Aswad, J. Baum, and M. Barza, “The effect of cleaning and disinfection of soft contact lenses on corneal infectivity in an animal model,” American Journal of Ophthalmology, vol. 119, no. 6, pp. 738–743, 1995. View at Scopus
  52. A. S. Kreger, D. M. Lyerly, L. D. Hazlett, and R. S. Berk, “Immunization against experimental Pseudomonas aeruginosa and Serratia marcescens keratitis. Vaccination with lipopolysaccharide endotoxins and proteases,” Investigative Ophthalmology & Visual Science, vol. 27, no. 6, pp. 932–939, 1986. View at Scopus
  53. M. P. Holzer, H. P. Sandoval, L. G. Vargas et al., “Corneal flap complications in refractive surgery: part 2: postoperative treatments of diffuse lamellar keratitis in an experimental animal model,” Journal of Cataract and Refractive Surgery, vol. 29, no. 4, pp. 803–807, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. M. P. Holzer, K. D. Solomon, D. T. Vroman et al., “Diffuse lamellar keratitis: evaluation of etiology, histopathologic findings, and clinical implications in an experimental animal model,” Journal of Cataract and Refractive Surgery, vol. 29, no. 3, pp. 542–549, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. M. P. Holzer, L. G. Vargas, H. P. Sandoval et al., “Corneal flap complications in refractive surgery part 1: development of an experimental animal model,” Journal of Cataract and Refractive Surgery, vol. 29, no. 4, pp. 795–802, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. M. P. Holzer, H. P. Sandoval, L. G. Vargas et al., “Evaluation of preoperative and postoperative prophylactic regimens for prevention and treatment of diffuse lamellar keratitis,” Journal of Cataract and Refractive Surgery, vol. 30, no. 1, pp. 195–199, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. B. A. Schlech, J. D. Hansard, and F. C. Bach, “Effectiveness of neomycin and polymyxin ointments: prevention of Staphylococcus aureus keratitis in rabbits,” Annals of Ophthalmology, vol. 7, no. 7, pp. 967–977, 1975. View at Scopus
  58. A. Kupferman and H. M. Leibowitz, “Quantitation of bacterial infection and antibiotic effect in the cornea,” Archives of Ophthalmology, vol. 94, no. 11, pp. 1981–1984, 1976. View at Scopus
  59. A. Kupferman and H. M. Leibowitz, “Topical antibiotic therapy of Staphylococcal keratitis,” Archives of Ophthalmology, vol. 95, no. 9, pp. 1634–1637, 1977. View at Scopus
  60. M. C. Callegan, J. M. Hill, M. S. Insler, J. A. Hobden, and R. J. O'Callaghan, “Methicillin-resistant Staphylococcus aureus keratitis in the rabbit: therapy with ciprofloxacin, vancomycin and cefazolin,” Current Eye Research, vol. 11, no. 11, pp. 1111–1119, 1992. View at Scopus
  61. M. C. Callegan, J. A. Hobden, J. M. Hill, M. S. Insler, and R. J. O'Callaghan, “Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis,” Investigative Ophthalmology & Visual Science, vol. 33, no. 11, pp. 3017–3023, 1992. View at Scopus
  62. M. C. Callegan, L. S. Engel, J. M. Hill, and R. J. O'Callaghan, “Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis,” Investigative Ophthalmology & Visual Science, vol. 35, no. 3, pp. 1033–1037, 1994. View at Scopus
  63. J. M. Moreau, L. C. Green, L. S. Engel, J. M. Hill, and R. J. O'Callaghan, “Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model,” Current Eye Research, vol. 17, no. 8, pp. 808–812, 1998. View at Publisher · View at Google Scholar · View at Scopus
  64. E. B. H. Hume, J. M. Moreau, L. L. Conerly et al., “Clarithromycin for experimental Staphylococcus aureus keratitis,” Current Eye Research, vol. 18, no. 5, pp. 358–362, 1999. View at Publisher · View at Google Scholar · View at Scopus
  65. J. J. Dajcs, E. B. H. Hume, J. M. Moreau, A. R. Caballero, B. M. Cannon, and R. J. O'Callaghan, “Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit,” Investigative Ophthalmology & Visual Science, vol. 41, no. 6, pp. 1432–1437, 2000. View at Scopus
  66. S. A. Melki, A. Safar, F. Yaghouti et al., “Effect of topical povidone-iodine versus topical ofloxacin on experimental Staphylococcus keratitis,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 238, no. 5, pp. 459–462, 2000. View at Publisher · View at Google Scholar · View at Scopus
  67. J. J. Dajcs, J. M. Moreau, D. W. Stroman et al., “The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis,” Current Eye Research, vol. 23, no. 1, pp. 60–63, 2001. View at Publisher · View at Google Scholar · View at Scopus
  68. J. J. Dajcs, J. M. Moreau, B. A. Thibodeaux et al., “Effectiveness of ciprofloxacin and ofloxacin in a prophylaxis model of Staphylococcus keratitis,” Cornea, vol. 20, no. 8, pp. 878–880, 2001. View at Publisher · View at Google Scholar · View at Scopus
  69. J. J. Dajcs, B. A. Thibodeaux, D. O. Girgis, M. D. Shaffer, S. M. Delvisco, and R. J. O'Callaghan, “Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit,” Investigative Ophthalmology & Visual Science, vol. 43, no. 12, pp. 3712–3716, 2002. View at Scopus
  70. J. J. Dajcs, B. A. Thibodeaux, M. E. Marquart, D. O. Girgis, M. Traidej, and R. J. O'Callaghan, “Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 6, pp. 1948–1952, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. H. Oguz, H. Ozbilge, E. Oguz, and T. Gurkan, “Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model,” Current Eye Research, vol. 30, no. 3, pp. 155–161, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. H. Oksuz, N. Duran, C. Tamer, M. Cetin, and S. Silici, “Effect of propolis in the treatment of experimental Staphylococcus aureus Keratitis in Rabbits,” Ophthalmic Research, vol. 37, no. 6, pp. 328–334, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. E. G. Romanowski, F. S. Mah, K. A. Yates, R. P. Kowalski, and Y. J. Gordon, “The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model,” American Journal of Ophthalmology, vol. 139, no. 5, pp. 867–877, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. N. Duran, A. Koc, H. Oksuz et al., “The protective role of topical propolis on experimental keratitis via nitric oxide levels in rabbits,” Molecular and Cellular Biochemistry, vol. 281, no. 1-2, pp. 153–161, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. Y. Fukaya, A. Kurita, H. Tsuruga et al., “Antibiotic effects of WP-0405, a thermo-setting ofloxacin gel, on methicillin-resistant Staphylococcus aureus keratitis in rabbits,” Journal of Ocular Pharmacology and Therapeutics, vol. 22, no. 4, pp. 258–266, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. E. G. Romanowski, F. S. Mah, R. P. Kowalski, K. A. Yates, and Y. J. Gordon, “Benzalkonium chloride enhances the antibacterial efficacy of gatifloxacin in an experimental rabbit model of intrastromal keratitis,” Journal of Ocular Pharmacology and Therapeutics, vol. 24, no. 4, pp. 380–384, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. T. Wada, T. Kida, T. Inoue, H. Tokushige, H. Naka, and H. Sakaki, “Immunomodulatory effect of gatifloxacin on mouse peritoneal macrophages in vitro and in models of endotoxin-induced rat conjunctivitis and rabbit bacterial keratitis,” Ophthalmic Research, vol. 40, no. 2, pp. 54–60, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. J. Wang, X. Li, L. Xiong, and N. Sun, “Different concentrations of clarithromycin ophthalmic gel for rabbits corneal ulcers induced by Staphylococcus aureus,” Yan Ke Xue Bao, vol. 24, no. 1, pp. 18–22, 2008.
  79. H. Eguchi, H. Shiota, S. Oguro, and T. Kasama, “The inhibitory effect of vancomycin ointment on the manifestation of MRSA keratitis in rabbits,” Journal of Infection and Chemotherapy, vol. 15, no. 5, pp. 279–283, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. C. C. McCormick, A. R. Caballero, C. L. Balzli, A. Tang, and R. J. O'Callaghan, “Chemical inhibition of alpha-toxin, a key corneal virulence factor of Staphylococcus aureus,” Investigative Ophthalmology & Visual Science, vol. 50, no. 6, pp. 2848–2854, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  81. M. E. Sanders, E. W. Norcross, Q. C. Moore, A. Shafiee, and M. E. Marquart, “Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis,” Cornea, vol. 28, no. 9, pp. 1055–1060, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. M. Saleh, F. Jehl, A. Dory et al., “Ocular penetration of topically applied linezolid in a rabbit model,” Journal of Cataract and Refractive Surgery, vol. 36, no. 3, pp. 488–492, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  83. M. E. Sanders, Q. C. Moore, E. W. Norcross, A. Shafiee, and M. E. Marquart, “Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis,” Journal of Ocular Pharmacology and Therapeutics, vol. 26, no. 2, pp. 193–198, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. J. M. Moreau, D. O. Girgis, E. B. H. Hume, J. J. Dajcs, M. S. Austin, and R. J. O'Callaghan, “Phospholipase A2 in rabbit tears: a host defense against Staphylococcus aureus,” Investigative Ophthalmology & Visual Science, vol. 42, no. 10, pp. 2347–2354, 2001. View at Scopus
  85. D. O. Girgis, J. J. Dajcs, and R. J. O'Callaghan, “Phospholipase A2 activity in normal and Staphylococcus aureus-infected rabbit eyes,” Investigative Ophthalmology & Visual Science, vol. 44, no. 1, pp. 197–202, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. R. J. O'Callaghan, D. O. Girgis, J. J. Dajcs, and G. D. Sloop, “Host defense against bacterial keratitis,” Ocular Immunology and Inflammation, vol. 11, no. 3, pp. 171–181, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. R. J. O'Callaghan, C. C. McCormick, A. R. Caballero, M. E. Marquart, H. P. Gatlin, and J. D. Fratkin, “Age-related differences in rabbits during experimental Staphylococcus aureus keratitis,” Investigative Ophthalmology & Visual Science, vol. 48, no. 11, pp. 5125–5131, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  88. M. C. Callegan, L. S. Engel, J. M. Hill, and R. J. O'Callaghan, “Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis,” Infection and Immunity, vol. 62, no. 6, pp. 2478–2482, 1994. View at Scopus
  89. J. J. Dajcs, M. S. Austin, G. D. Sloop et al., “Corneal pathogenesis of Staphylococcus aureus strain Newman,” Investigative Ophthalmology & Visual Science, vol. 43, no. 4, pp. 1109–1115, 2002. View at Scopus
  90. J. J. Dajcs, B. A. Thibodeaux, D. O. Girgis, and R. J. O'Callaghan, “Corneal virulence of Staphylococcus aureus in an experimental model of keratitis,” DNA and Cell Biology, vol. 21, no. 5-6, pp. 375–382, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  91. R. J. O'Callaghan, M. C. Callegan, J. M. Moreau et al., “Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection,” Infection and Immunity, vol. 65, no. 5, pp. 1571–1578, 1997. View at Scopus
  92. E. B. H. Hume, J. J. Dajcs, J. M. Moreau, and R. J. O'Callaghan, “Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis,” Infection and Immunity, vol. 68, no. 10, pp. 6052–6055, 2000. View at Publisher · View at Google Scholar · View at Scopus
  93. E. B. H. Hume, J. J. Dajcs, J. M. Moreau, G. D. Sloop, M. D. P. Willcox, and R. J. O'Callaghan, “Staphylococcus corneal virulence in a new topical model of Infection,” Investigative Ophthalmology & Visual Science, vol. 42, no. 12, pp. 2904–2908, 2001. View at Scopus
  94. P. Z. J. Wu, H. Zhu, F. Stapleton et al., “Effects of α-toxin-deficient Staphylococcus aureus on the production of peripheral corneal ulceration in an animal model,” Current Eye Research, vol. 30, no. 1, pp. 63–70, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. N. Cole, E. B. Hume, A. K. Vijay, P. Sankaridurg, N. Kumar, and M. D. Willcox, “In vivo performance of melimine as an antimicrobial coating for contact lenses in models of CLARE and CLPU,” Investigative Ophthalmology & Visual Science, vol. 51, no. 1, pp. 390–395, 2010. View at Scopus
  96. C. L. Balzli, C. C. McCormick, A. R. Caballero et al., “Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis,” Journal of Cataract and Refractive Surgery, vol. 34, no. 2, pp. 295–301, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  97. S. N. Rao, Y. C. Fong, J. Kampmeier, L. D. Labree, D. J. Tanzer, and P. J. McDonnell, “The effectiveness of a topical antibiotic irrigating solution in a model of staphylococcal keratitis after lamellar keratectomy,” American Journal of Ophthalmology, vol. 130, no. 1, pp. 20–24, 2000. View at Publisher · View at Google Scholar · View at Scopus
  98. T. Tungsiripat, M. A. Sarayba, M. B. Kaufman et al., “Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit model,” American Journal of Ophthalmology, vol. 136, no. 1, pp. 76–81, 2003. View at Publisher · View at Google Scholar · View at Scopus
  99. F. S. Mah, E. G. Romanowski, D. K. Dhaliwal, K. A. Yates, and Y. J. Gordon, “Role of topical fluoroquinolones on the pathogenesis of diffuse lamellar keratitis in experimental in vivo studies,” Journal of Cataract and Refractive Surgery, vol. 32, no. 2, pp. 264–268, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  100. M. K. Johnson, J. A. Hobden, M. Hagenah, R. J. O'Callaghan, J. M. Hill, and S. Chen, “The role of pneumolysin in ocular infections with Streptococcus pneumoniae,” Current Eye Research, vol. 9, no. 11, pp. 1107–1114, 1990. View at Scopus
  101. L. D. Hazlett, M. M. Moon, M. Strejc, and R. S. Berk, “Evidence for N-acetylmannosamine as an ocular receptor for P. aeruginosa adherence to scarified cornea,” Investigative Ophthalmology & Visual Science, vol. 28, no. 12, pp. 1978–1985, 1987. View at Scopus
  102. J. R. Gerke and M. V. Magliocco, “Experimental Pseudomonas aeruginosa infection of the mouse cornea,” Infection and Immunity, vol. 3, pp. 209–216, 1971.
  103. J. R. Gerke and J. S. Nelson, “Oral vaccination and multivalent vaccine against Pseudomonas aeruginosa keratitis,” Investigative Ophthalmology & Visual Science, vol. 16, no. 1, pp. 76–80, 1977. View at Scopus
  104. E. Jackson and F. W. Hartman, “Experimental Bacillus pyocyaneus keratitis,” The Journal of Laboratory and Clinical Medicine, vol. 12, no. 5, pp. 442–450, 1927. View at Scopus
  105. K. Kawaharajo and J. Y. Homma, “Synergistic effect of immune gamma-globulin fraction on protection by antibiotic against corneal ulcers in experimental mice infected with Pseudomonas aeruginosa,” The Japanese Journal of Experimental Medicine, vol. 46, no. 3, pp. 155–165, 1976.
  106. Y. Hirao and J. Y. Homma, “Therapeutic effect of immunization with OEP, protease toxoid and elastase toxoid corneal ulcers in mice due to Pseudomonas aeruginosa infection,” Japanese Journal of Experimental Medicine, vol. 48, no. 1, pp. 41–51, 1978. View at Scopus
  107. M. M. Moon, L. D. Hazlett, R. E. W. Hancock, R. S. Berk, and R. Barrett, “Monoclonal antibodies provide protection against ocular Pseudomonas aeruginosa infection,” Investigative Ophthalmology & Visual Science, vol. 29, no. 8, pp. 1277–1284, 1988. View at Scopus
  108. T. S. Zaidi, G. P. Priebe, and G. B. Pier, “A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection,” Infection and Immunity, vol. 74, no. 2, pp. 975–983, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  109. Y. Tanaka, “Effects of habekacin, a novel aminoglycoside antibiotic, on experimental corneal ulceration due to Pseudomonas aeruginosa,” Journal of Antibiotics, vol. 34, no. 7, pp. 892–898, 1981. View at Scopus
  110. E. J. Lee, T. N. Truong, M. N. Mendoza, and S. M. J. Fleiszig, “A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics,” Current Eye Research, vol. 27, no. 5, pp. 289–299, 2003. View at Publisher · View at Google Scholar · View at Scopus
  111. P. Karicherla, S. Aras, A. Aiyar, and J. A. Hobden, “Nona-D-arginine amide suppresses corneal cytokines in Pseudomonas aeruginosa keratitis,” Cornea, vol. 29, no. 11, pp. 1308–1314, 2010. View at Publisher · View at Google Scholar · View at PubMed
  112. P. Karicherla and J. A. Hobden, “Nona-D-arginine amide for prophylaxis and treatment of experimental Pseudomonas aeruginosa keratitis,” Current Eye Research, vol. 35, no. 3, pp. 220–224, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  113. A. Kumar, L. D. Hazlett, and F.-S. X. Yu, “Flagellin suppresses the inflammatory response and enhances bacterial clearance in a murine model of Peudomonas aeruginosa keratitis,” Infection and Immunity, vol. 76, no. 1, pp. 89–96, 2008. View at Publisher · View at Google Scholar · View at PubMed
  114. M. S. F. Kwong, D. J. Evans, M. Ni, B. A. Cowell, and S. M. J. Fleiszig, “Human tear fluid protects against Pseudomonas aeruginosa keratitis in a murine experimental model,” Infection and Immunity, vol. 75, no. 5, pp. 2325–2332, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  115. A. Thakur, R. P. Barrett, J. A. Hobden, and L. D. Hazlett, “Caspase-1 inhibitor reduces severity of Pseudomonas aeruginosa keratitis in mice,” Investigative Ophthalmology & Visual Science, vol. 45, no. 9, pp. 3177–3184, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  116. X. Huang, R. P. Barrett, S. A. McClellan, and L. D. Hazlett, “Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis,” Investigative Ophthalmology & Visual Science, vol. 46, no. 11, pp. 4209–4216, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  117. M. Wu, S. A. McClellan, R. P. Barrett, and L. D. Hazlett, “β-defensin-2 promotes resistance against infection with P. aeruginosa,” Journal of Immunology, vol. 182, no. 3, pp. 1609–1616, 2009. View at Scopus
  118. E. B. H. Hume, N. Cole, L. L. Garthwaite, S. Khan, and M. D. P. Willcox, “A protective role for IL-6 in staphylococcal microbial keratitis,” Investigative Ophthalmology & Visual Science, vol. 47, no. 11, pp. 4926–4930, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  119. L. D. Hazlett, S. A. McClellan, R. P. Barrett, J. Liu, Y. Zhang, and S. Lighvani, “Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection,” Investigative Ophthalmology & Visual Science, vol. 48, no. 2, pp. 797–807, 2007. View at Publisher · View at Google Scholar · View at PubMed
  120. M. L. Xue, A. Thakur, N. Cole et al., “A critical role for CCL2 and CCL3 chemokines in the regulation of polymorphonuclear neutrophils recruitment during corneal infection in mice,” Immunology and Cell Biology, vol. 85, no. 7, pp. 525–531, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  121. T. Zaidi, M. Bajmoczi, T. Zaidi, D. E. Golan, and G. B. Pier, “Disruption of CFTR-dependent lipid rafts reduces bacterial levels and corneal disease in a murine model of Pseudomonas aeruginosa keratitis,” Investigative Ophthalmology & Visual Science, vol. 49, no. 3, pp. 1001–1009, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  122. T. Zaidi and G. B. Pier, “Prophylactic and therapeutic efficacy of a fully human immunoglobulin G1 monoclonal antibody to Pseudomonas aeruginosa alginate in murine keratitis infection,” Infection and Immunity, vol. 76, no. 10, pp. 4720–4725, 2008.
  123. S. M. J. Fleiszig, T. S. Zaidi, E. L. Fletcher, M. J. Preston, and G. B. Pier, “Pseudomonas aeruginosa invades corneal epithelial cells during experimental infection,” Infection and Immunity, vol. 62, no. 8, pp. 3485–3493, 1994. View at Scopus
  124. S. M. J. Fleiszig, T. S. Zaidi, and G. B. Pier, “Pseudomonas aeruginosa invasion of and multiplication within corneal epithelial cells in vitro,” Infection and Immunity, vol. 63, no. 10, pp. 4072–4077, 1995. View at Scopus
  125. E. J. Lee, B. A. Cowell, D. J. Evans, and S. M. J. Fleiszig, “Contribution of ExsA-regulated factors to corneal infection by cytotoxic and invasive Pseudomonas aeruginosa in a murine scarification model,” Investigative Ophthalmology & Visual Science, vol. 44, no. 9, pp. 3892–3898, 2003. View at Publisher · View at Google Scholar · View at Scopus
  126. E. J. Lee, D. J. Evans, and S. M. J. Fleiszig, “Role of Pseudomonas aeruginosa ExsA in penetration through corneal epithelium in a novel in vivo model,” Investigative Ophthalmology & Visual Science, vol. 44, no. 12, pp. 5220–5227, 2003. View at Publisher · View at Google Scholar · View at Scopus
  127. R. J. O'Callaghan, L. S. Engel, J. A. Hobden, M. C. Callegan, L. C. Green, and J. M. Hill, “Pseudomonas keratitis: the role of an uncharacterized exoprotein, protease IV, in corneal virulence,” Investigative Ophthalmology & Visual Science, vol. 37, no. 4, pp. 534–543, 1996. View at Scopus
  128. L. S. Engel, J. A. Hobden, J. M. Moreau, M. C. Callegan, J. M. Hill, and R. J. O'Callaghan, “Pseudomonas deficient in protease IV has significantly reduced corneal virulence,” Investigative Ophthalmology & Visual Science, vol. 38, no. 8, pp. 1535–1542, 1997. View at Scopus
  129. M. J. Preston, P. C. Seed, D. S. Toder et al., “Contribution of proteases and LasR to the virulence of Pseudomonas aeruginosa during corneal infections,” Infection and Immunity, vol. 65, no. 8, pp. 3086–3090, 1997. View at Scopus
  130. J. A. Hobden, “Pseudomonas aeruginosa proteases and corneal virulence,” DNA and Cell Biology, vol. 21, no. 5-6, pp. 391–396, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  131. L. D. Hazlett, D. D. Rosen, and R. S. Berk, “Pseudomonas eye infections in cyclophosphamide treated mice,” Investigative Ophthalmology & Visual Science, vol. 16, no. 7, pp. 649–652, 1977. View at Scopus
  132. L. D. Hazlett, M. Zucker, and R. S. Berk, “Distribution and kinetics of the inflammatory cell response to ocular challenge with Pseudomonas aeruginosa in susceptible versus resistant mice,” Ophthalmic Research, vol. 24, no. 1, pp. 32–39, 1992. View at Scopus
  133. J. A. Hobden, S. A. Masinick, R. P. Barrett, and L. D. Hazlett, “Aged mice fail to upregulate ICAM-1 after Pseudomonas aeruginosa corneal infection,” Investigative Ophthalmology & Visual Science, vol. 36, no. 6, pp. 1107–1114, 1995. View at Scopus
  134. J. A. Hobden, S. A. Masinick, R. P. Barrett, and L. D. Hazlett, “Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice,” Infection and Immunity, vol. 65, no. 7, pp. 2754–2758, 1997. View at Scopus
  135. K. A. Kernacki and R. S. Berk, “Characterization of arachidonic acid metabolism and the polymorphonuclear leukocyte response in mice infected intracorneally with Pseudomonas aeruginosa,” Investigative Ophthalmology & Visual Science, vol. 36, no. 1, pp. 16–23, 1995. View at Scopus
  136. K. A. Kernacki, R. P. Barrett, J. A. Hobden, and L. D. Hazlett, “Macrophage inflammatory protein-2 is a mediator of polymorphonuclear neutrophil influx in ocular bacterial infection,” Journal of Immunology, vol. 164, no. 2, pp. 1037–1045, 2000. View at Scopus
  137. K. A. Kernacki, R. P. Barrett, S. A. McClellan, and L. D. Hazlett, “Aging and PMN response to P. aeruginosa infection,” Investigative Ophthalmology & Visual Science, vol. 41, no. 10, pp. 3019–3025, 2000. View at Scopus
  138. D. O. Girgis, G. D. Sloop, J. M. Reed, and R. J. O'Callaghan, “A new topical model of Staphylococcus corneal infection in the mouse,” Investigative Ophthalmology & Visual Science, vol. 44, no. 4, pp. 1591–1597, 2003. View at Publisher · View at Google Scholar · View at Scopus
  139. D. O. Girgis, G. D. Sloop, J. M. Reed, and R. J. O'Callaghan, “Susceptibility of aged mice to Staphylococcus aureus keratitis,” Current Eye Research, vol. 29, no. 4-5, pp. 269–275, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  140. D. O. Girgis, G. D. Sloop, J. M. Reed, and R. J. O'Callaghan, “Effects of toxin production in a murine model of Staphylococcus aureus keratitis,” Investigative Ophthalmology & Visual Science, vol. 46, no. 6, pp. 2064–2070, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  141. E. B. H. Hume, N. Cole, S. Khan et al., “A Staphylococcus aureus mouse keratitis topical infection model: cytokine balance in different strains of mice,” Immunology and Cell Biology, vol. 83, no. 3, pp. 294–300, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  142. Y. Sun, A. G. Hise, C. M. Kalsow, and E. Pearlman, “Staphylococcus aureus-induced corneal inflammation is dependent on toll-like receptor 2 and myeloid differentiation factor 88,” Infection and Immunity, vol. 74, no. 9, pp. 5325–5332, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  143. N. Cole, M. Krockenberger, F. Stapleton et al., “Experimental Pseudomonas aeruginosa keratitis in interleukin-10 gene knockout mice,” Infection and Immunity, vol. 71, no. 3, pp. 1328–1336, 2003. View at Publisher · View at Google Scholar · View at Scopus
  144. N. Cole, E. B. Hume, S. Khan et al., “The corneal response to infection with Staphylococcus aureus in the absence of interleukin-4,” Immunology and Cell Biology, vol. 85, no. 4, pp. 333–337, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  145. E. B. H. Hume, N. Cole, L. L. Garthwaite, S. Khan, and M. D. P. Willcox, “A protective role for IL-6 in staphylococcal microbial keratitis,” Investigative Ophthalmology & Visual Science, vol. 47, no. 11, pp. 4926–4930, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  146. S. Khan, N. Cole, E. B. Hume et al., “The role of CXC chemokine receptor 2 in Pseudomonas aeruginosa corneal infection,” Journal of Leukocyte Biology, vol. 81, no. 1, pp. 315–318, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  147. X. Huang, W. Du, S. A. McClellan, R. P. Barrett, and L. D. Hazlett, “TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis,” Investigative Ophthalmology & Visual Science, vol. 47, no. 11, pp. 4910–4916, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  148. T. S. Zaidi, T. Zaidi, and G. B. Pier, “Role of neutrophils, MyD88-mediated neutrophil recruitment, and complement in antibody-mediated defense against Pseudomonas aeruginosa keratitis,” Investigative Ophthalmology & Visual Science, vol. 51, no. 4, pp. 2085–2093, 2010. View at Scopus
  149. A. Thakur, R. P. Barrett, S. McClellan, and L. D. Hazlett, “Regulation of Pseudomonas aeruginosa corneal infection in IL-1β converting enzyme (ICE, caspase-1) deficient mice,” Current Eye Research, vol. 29, no. 4-5, pp. 225–233, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  150. S. A. McClellan, X. Huang, R. P. Barrett et al., “Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection,” Investigative Ophthalmology & Visual Science, vol. 47, no. 1, pp. 256–264, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  151. Z. Zhou, M. Wu, R. P. Barrett, S. A. McClellan, Y. Zhang, and L. D. Hazlett, “Role of the Fas pathway in Pseudomonas aeruginosa keratitis,” Investigative Ophthalmology & Visual Science, vol. 51, no. 5, pp. 2537–2547, 2010.
  152. Y. Sun, M. Karmakar, S. Roy et al., “TLR4 and TLR5 on corneal macrophages regulate Pseudomonas aeruginosa keratitis by signaling through MyD88-dependent and -independent pathways,” Journal of Immunology, vol. 185, no. 7, pp. 4272–4283, 2010. View at Publisher · View at Google Scholar · View at PubMed
  153. M. Gadjeva, J. Nagashima, T. Zaidi, R. A. Mitchell, and G. B. Pier, “Inhibition of macrophage migration inhibitory factor ameliorates ocular Pseudomonas aeruginosa-induced keratitis,” PLoS Pathogens, vol. 6, no. 3, Article ID e1000826, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  154. A. Ghosh, S. Lee, R. Dziarski, and S. Chakravarti, “A novel antimicrobial peptidoglycan recognition protein in the cornea,” Investigative Ophthalmology & Visual Science, vol. 50, no. 9, pp. 4185–4191, 2009. View at Scopus
  155. L. C. Huang, R. Y. Reins, R. L. Gallo, and A. M. McDermott, “Cathelicidin-deficient (Cnlp/) mice show increased susceptibility to Pseudomonas aeruginosa keratitis,” Investigative Ophthalmology & Visual Science, vol. 48, no. 10, pp. 4498–4508, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  156. S. D. Davis and J. W. Chandler, “Experimental keratitis due to Pseudomonas aeruginosa: model for evaluation of antimicrobial drugs,” Antimicrobial Agents and Chemotherapy, vol. 8, no. 3, pp. 350–355, 1975. View at Scopus
  157. S. D. Davis, L. D. Sarff, and R. A. Hyndiuk, “Staphylococcal keratitis. Experimental model in guinea pigs,” Archives of Ophthalmology, vol. 96, no. 11, pp. 2114–2116, 1978. View at Scopus
  158. S. D. Davis, L. D. Sarff, and R. A. Hyndiuk, “Comparison of therapeutic routes in experimental Pseudomonas keratitis,” American Journal of Ophthalmology, vol. 87, no. 5, pp. 710–716, 1979. View at Scopus
  159. S. D. Davis, L. D. Sarff, and R. A. Hyndiuk, “Relative efficay of the topical use of amikacin, gentamicin and tobramycin in experimental Pseudomonas keratitis,” Canadian Journal of Ophthalmology, vol. 15, no. 1, pp. 28–29, 1980. View at Scopus
  160. C. Ohadi, K. L. Litwin, H. Moreira et al., “Anti-inflammatory therapy and outcome in a guinea pig model of Pseudomonas keratitis,” Cornea, vol. 11, no. 5, pp. 398–403, 1992. View at Scopus
  161. A. K. Vijay, P. Sankaridurg, H. Zhu, and M. D. Willcox, “Guinea pig models of acute keratitis responses,” Cornea, vol. 28, no. 10, pp. 1153–1159, 2009. View at Scopus
  162. J. D. Choo, B. A. Holden, E. B. Papas, and M. D. P. Willcox, “Adhesion of Pseudomonas aeruginosa to orthokeratology and alignment lenses,” Optometry and Vision Science, vol. 86, no. 2, pp. 93–97, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  163. K. H. Dannelly, Y. Liu, and S. K. Ghosh, “Pseudomonas aeruginosa corneal infection affects cholinergic enzymes in rat lacrimal gland,” Archives of Microbiology, vol. 177, no. 1, pp. 47–53, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  164. I. S. Barequet, Z. Habot-Wilner, N. Keller et al., “Effect of amniotic membrane transplantation on the healing of bacterial keratitis,” Investigative Ophthalmology & Visual Science, vol. 49, no. 1, pp. 163–167, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  165. E. A. Szliter, R. P. Barrett, M. M. Gabriel, Y. Zhang, and L. D. Hazlett, “Pseudomonas aeruginosa—induced inflammation in the rat extended-wear contact lens model,” Eye and Contact Lens, vol. 32, no. 1, pp. 12–18, 2006. View at Publisher · View at Google Scholar · View at Scopus
  166. C. Tam, J. J. Mun, D. J. Evans, and S. M. Fleiszig, “The impact of inoculation parameters on the pathogenesis of contact lens-related infectious keratitis,” Investigative Ophthalmology & Visual Science, vol. 51, no. 6, pp. 3100–3106, 2010. View at Scopus
  167. W. Behrens-Baumann, H. -H. Paul, and R. Ansorg, “Treatment of Pseudomonas aeruginosa keratitis with tobramycin and gentamicin: an animal experimental study,” Klinische Monatsblatter fur Augenheilkunde, vol. 178, no. 3, pp. 197–199, 1981.
  168. P. R. Badenoch, G. J. Hay, P. J. McDonald, and D. J. Coster, “A rat model of bacterial keratitis. Effect of antibiotics and corticosteroid,” Archives of Ophthalmology, vol. 103, no. 5, pp. 718–722, 1985. View at Scopus
  169. P. R. Badenoch, P. J. McDonald, and D. J. Coster, “Effect of inflammation on antibiotic penetration into the anterior segment of the rat eye,” Investigative Ophthalmology & Visual Science, vol. 27, no. 6, pp. 958–965, 1986. View at Scopus
  170. S. S. Twining, X. Zhou, D. P. Schulte, P. M. Wilson, B. Fish, and J. Moulder, “Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis,” Investigative Ophthalmology & Visual Science, vol. 37, no. 4, pp. 511–522, 1996. View at Scopus
  171. S. Hayes, C. Boote, J. Lewis et al., “Comparative study of fibrillar collagen arrangement in the corneas of primates and other mammals,” Anatomical Record, vol. 290, no. 12, pp. 1542–1550, 2007. View at Publisher · View at Google Scholar · View at PubMed
  172. J. T. Henriksson, A. M. McDermott, and J. P. Bergmanson, “Dimensions and morphology of the cornea in three strains of mice,” Investigative Ophthalmology & Visual Science, vol. 50, no. 8, pp. 3648–3654, 2009. View at Scopus
  173. J. V. Jester, A. Budge, S. Fisher, and J. Huang, “Corneal keratocytes: phenotypic and species differences in abundant protein expression and in vitro light-scattering,” Investigative Ophthalmology & Visual Science, vol. 46, no. 7, pp. 2369–2378, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  174. J. L. Ojeda, J. A. Ventosa, and S. Piedra, “The three-dimensional microanatomy of the rabbit and human cornea. A chemical and mechanical microdissection-SEM approach,” Journal of Anatomy, vol. 199, no. 5, pp. 567–576, 2001.
  175. S. Hayashi, T. Osawa, and K. Tohyama, “Comparative observations on corneas, with special reference to Bowman's layer and Descemet's membrane in mammals and amphibians,” Journal of Morphology, vol. 254, no. 3, pp. 247–258, 2002. View at Publisher · View at Google Scholar · View at PubMed
  176. M. Reichard, M. Hovakimyan, A. Wree et al., “Comparative in vivo confocal microscopical study of the cornea anatomy of different laboratory animals,” Current Eye Research, vol. 35, no. 12, pp. 1072–1080, 2010. View at Publisher · View at Google Scholar · View at PubMed
  177. J. E. Schechter, D. W. Warren, and A. K. Mircheff, “A lacrimal gland is a lacrimal gland, but rodent's and rabbit's are not human,” Ocular Surface, vol. 8, no. 3, pp. 111–134, 2010.
  178. L. Royle, E. Matthews, A. Corfield et al., “Glycan structures of ocular surface mucins in man, rabbit and dog display species differences,” Glycoconjugate Journal, vol. 25, no. 8, pp. 763–773, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus